Cathie Wood’s ARK ETF has recently made some significant adjustments to its portfolio by making major purchases in CRISPR and Aurora. This move has caught the attention of investors and analysts alike. ARK ETF, managed by Cathie Wood, is known for its focus on disruptive technologies and innovative companies.
CRISPR is a gene-editing technology that has the potential to revolutionize the healthcare industry by allowing scientists to edit DNA sequences. The technology has shown promise in treating genetic disorders and diseases, making it an exciting investment opportunity for ARK ETF.
Aurora, on the other hand, is a cannabis company that has been making waves in the industry with its innovative products and strong market presence. ARK ETF’s decision to invest in Aurora reflects its bullish outlook on the cannabis sector and its potential for growth.
Overall, Cathie Wood’s ARK ETF continues to make bold moves in the market, positioning itself as a leader in investing in disruptive technologies and innovative companies. Investors will be watching closely to see how these recent purchases play out in the coming months.